From USFDA
Shasun Pharmaceuticals announced that it has received approval from the United States Food & Drug Administration for Carisoprodol Tablets USP 250 mg and 350 mg. The product will be manufactured at the Pondicherry facility of the company and distributed in US through a partner. The product is expected to be launched shortly.Powered by Capital Market - Live News
